Why Veracyte (VCYT) is a Top Momentum Stock for the Long-Term

Veracyte (VCYT), a global diagnostics company, is highlighted by Zacks for its strong momentum, holding a #3 (Hold) rank with a B VGM Score and a B Momentum Style Score. The company's shares have climbed 10.2% over the past four weeks, buoyed by three analyst upward revisions to fiscal 2025 earnings estimates, which increased the Zacks Consensus Estimate to $1.39 per share, and an average earnings surprise of +242.8%. This combination of positive price action, upward earnings revisions, and favorable Zacks Style Scores positions VCYT as a notable consideration for investors.

Analysis

Veracyte (VCYT), a global diagnostics company, presents a mixed but predominantly positive momentum profile based on its recent performance and forward-looking estimates. The stock has demonstrated strong price momentum, rallying 10.2% over the past four weeks. This is supported by fundamental optimism, as three analysts have revised their fiscal 2025 earnings estimates upward in the last 60 days, increasing the Zacks Consensus Estimate to $1.39 per share. Furthermore, VCYT has a compelling history of outperformance, with an average earnings surprise of +242.8%, indicating a consistent ability to exceed market expectations. However, these bullish factors are tempered by its current Zacks Rank of #3 (Hold), which suggests a neutral short-term outlook according to the model. While the stock earns favorable 'B' ratings for both its overall VGM and specific Momentum Style Scores, the 'Hold' rank itself warrants consideration, creating a divergence between the strong quantitative momentum and the proprietary rating.

Key Decisions for Investors

• Investors with a momentum-driven strategy should note the stock's 10.2% recent gain and positive earnings estimate revisions, but remain aware that the neutral #3 (Hold) rank could signal a potential for near-term consolidation.
• Given the substantial average earnings surprise of +242.8%, it is prudent to investigate whether this pattern stems from conservative company guidance or persistent analyst underestimation, as this context is crucial for assessing future growth potential.
• For those considering a new position, the conflicting signals may justify placing VCYT on a watchlist, awaiting a potential upgrade in the Zacks Rank to a #1 (Strong Buy) or #2 (Buy) which would provide a stronger confirmation of the positive underlying trends.